MCCP
BIIB icon

Mission Creek Capital Partners’s Biogen BIIB Stock Holding History

Mission Creek Capital Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-795
Closed -$226K – 211
2020
Q3 		$226K Sell
795
-110
-12% -$30.7K 0.09% 188
2020
Q2 		$242K Buy
905
+5
+0.6% +$1.5K 0.13% 154
2020
Q1 		$285K Sell
900
-70
-7% -$21.2K 0.15% 132
2019
Q4 		$288K Buy
+970
New +$269K 0.13% 159

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mission Creek Capital Partners's BIIB Position: Q4 2020 in Review

Mission Creek Capital Partners sold out of Biogen (BIIB) in Q4 2020, closing a stake of 795 shares — an estimated $226K sold.

Mission Creek Capital Partners first reported a position in BIIB in Q4 2019 and held it in 4 quarters. The position peaked at $288K in Q4 2019. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

  • Mission Creek Capital Partners reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
  • Mission Creek Capital Partners sold 795 Biogen shares in Q4 2020, an estimated $226K.
  • Mission Creek Capital Partners first reported a position in Biogen in Q4 2019 and held it in 4 quarters.
  • Mission Creek Capital Partners's Biogen position peaked at $288K in Q4 2019.
  • 1,060 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on Mission Creek Capital Partners's 13F filing for Q4 2020, filed 16 Feb 2021.